Table 3.
Demographics and clinical parameters of patients with echinococcosis treated surgically with or without anaphylactic shock (N = 90)
| Shock (N = 18) | Control (N = 72) | |
|---|---|---|
| Age (years) | 32.61 ± 22.41 | 46.20 ± 16.84 |
| Gender, n (%) | ||
| Male | 8 (44.44) | 36 (45.00) |
| Female | 10 (55.56) | 44 (55.00) |
| White blood cell (109/L) | 9.45 ± 4.64 | 8.95 ± 2.47 |
| Neutrophil (109/L) | 10.56 ± 19.47 | 5.42 ± 1.93 |
| Neutrophil (%) | 0.67 ± 0.17 | 0.67 ± 0.15 |
| Lymphocyte (109/L) | 2.01 ± 1.27 | 2.07 ± 1.04 |
| Lymphocyte (%) | 0.22 ± 0.11 | 0.23 ± 0.12 |
| Monocyte (109/L) | 0.57 ± 0.43 | 0.60 ± 0.46 |
| Monocyte (%) | 0.06 ± 0.02 | 0.07 ± 0.03 |
| Eosinophil, (109/L) | 0.53 ± 0.72 | 0.40 ± 0.33 |
| Eosinophil (%) | 0.05 ± 0.07 | 0.05 ± 0.06 |
| Basophil (109/L) | 0.09 ± 0.05 | 0.07 ± 0.09 |
| Basophil (%) | 0.01 ± 0.01 | 0.01 ± 0.01 |